Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Human IgG1 Isotype Control Antibody (5Vk2/37.7H)


Proteo Genix logo
View Antibody details

Human IgG1 Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details

Human IgG1 Isotype Control antibody (REA293)


Proteo Genix logo
View Antibody details

Human IgG1 kappa Isotype Control antibody


Proteo Genix logo
View Antibody details

Human IgG1 LALA Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details

Human IgG1 LALA P329G Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details

Human IgG1 lambda Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details

Human IgG1fut Isotype Control antibody (13R4)


Proteo Genix logo
View Antibody details

Human IgG2 Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details

Human IgG3 Isotype Control antibody (HyHEL-10)


Proteo Genix logo
View Antibody details